Hjem › Seglcelle-anæmi
Seglcelle-anæmi kliniske forsøg rekrutterer i USA
107 studier for Seglcelle-anæmi rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Atlanta, GA22 studier
- Washington, DC20 studier
- Memphis, TN18 studier
- Chicago, IL18 studier
- Philadelphia, PA15 studier
- Birmingham, AL14 studier
- New York City, NY13 studier
- St. Louis, MO12 studier
- Durham, NC10 studier
- Cincinnati, OH10 studier
- Houston, TX10 studier
- Boston, MA10 studier
- Greenville, NC9 studier
- Pittsburgh, PA9 studier
- Columbus, OH9 studier
- The Bronx, NY8 studier
- Cleveland, OH7 studier
- Baltimore, MD7 studier
- Los Angeles, CA7 studier
- Charlotte, NC7 studier
- Oakland, CA7 studier
- Nashville, TN6 studier
- Richmond, VA6 studier
- Augusta, GA5 studier
- Hartford, CT5 studier
- Detroit, MI5 studier
- Phoenix, AZ5 studier
- Jackson, MS5 studier
- Indianapolis, IN5 studier
- New Orleans, LA4 studier
- Arlington, VA4 studier
- Greenville, SC4 studier
- Milwaukee, WI4 studier
- New Haven, CT4 studier
- Greenburgh, NY3 studier
- Newark, NJ3 studier
- Mobile, AL3 studier
- Rochester, NY3 studier
- Minneapolis, MN3 studier
- Little Rock, AR3 studier
Efter delstat
- Alabama16 studier
- Arizona5 studier
- Arkansas3 studier
- Californien18 studier
- Connecticut7 studier
- Delaware6 studier
- District of Columbia10 studier
- Florida9 studier
- Georgia25 studier
- Illinois19 studier
- Indiana5 studier
- Louisiana5 studier
- Maryland17 studier
- Massachusetts10 studier
- Michigan9 studier
- Minnesota5 studier
- Mississippi5 studier
- Missouri13 studier
- New Jersey8 studier
- New York21 studier
- North Carolina18 studier
- Ohio22 studier
- Pennsylvania20 studier
- South Carolina6 studier
- Tennessee22 studier
- Texas11 studier
- Virginia9 studier
- Wisconsin4 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Exercise in Child Health
RekruttererFrivillige med god helbredstilstand velkomne
Alder 10 til 17 · Alle køn · Opdateret 2. okt. 2026 · NCT05359991Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 70 · Alle køn · Opdateret 2. okt. 2026 · NCT03937817A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT04055818Blood Sampling for Research Related to Sickle Cell Disease
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 100 · Alle køn · Opdateret 29. sep. 2026 · NCT00542230A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07656415Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
RekruttererTidlig fase 1
Alder 18 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT06313398A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
RekruttererFase 3
Alder 12 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT06439082A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07187973A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
RekruttererFase 3
Alder 2 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT06609226Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
RekruttererObservationsstudie
Alder 18 til 120 · Alle køn · Opdateret 18. sep. 2026 · NCT05170412A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT06612268Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
RekruttererFase 1
Alder 18 til 65 · Alle køn · Opdateret 17. sep. 2026 · NCT05904093Tocilizumab for Acute Chest Syndrome
RekruttererFase 2
Alder 12 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT05640271Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 12 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT02824471Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
RekruttererObservationsstudie
Alder 2 til 99 · Alle køn · Opdateret 11. sep. 2026 · NCT06944067Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing
Rekrutterer
Alder 8 til 18 · Alle køn · Opdateret 10. sep. 2026 · NCT07562451Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
RekruttererFase 1
Alder 8 til 17 · Alle køn · Opdateret 9. sep. 2026 · NCT07226219Early Screening and Treatment of Heart Complication in Sickle Cell Disease
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07023666A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 12 til 55 · Alle køn · Opdateret 9. sep. 2026 · NCT06546670SCD Stem Cell Mobilization and Apheresis Using Motixafortide
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06442761Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
RekruttererFase 1/2
Alder 4 til 65 · Alle køn · Opdateret 4. sep. 2026 · NCT07599176Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
RekruttererFase 2
Alder 5 til 20 · Alle køn · Opdateret 2. sep. 2026 · NCT07369024Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
RekruttererFase 1
Alder 18 til 90 · Alle køn · Opdateret 24. aug. 2026 · NCT07566494Cerebrovascular Reactivity Measurements With High-Density Diffuse Optical Tomography
RekruttererFrivillige med god helbredstilstand velkomne
Alder 6 til 70 · Alle køn · Opdateret 20. aug. 2026 · NCT07776444A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT06481306Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.